vs

Side-by-side financial comparison of Abbott Laboratories (ABT) and Apollo Global Management (APO). Click either name above to swap in a different company.

Abbott Laboratories is the larger business by last-quarter revenue ($11.5B vs $9.9B, roughly 1.2× Apollo Global Management). Abbott Laboratories runs the higher net margin — 15.5% vs 6.9%, a 8.6% gap on every dollar of revenue. On growth, Apollo Global Management posted the faster year-over-year revenue change (86.7% vs 4.4%). Over the past eight quarters, Apollo Global Management's revenue compounded faster (18.4% CAGR vs 7.2%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Apollo Global Management, Inc. is an American asset management firm that primarily invests in alternative assets. As of 2025, the company had $840 billion of assets under management, including $392 billion invested in credit, including mezzanine capital, hedge funds, non-performing loans, and collateralized loan obligations, $99 billion invested in private equity, and $46.2 billion invested in real assets, which includes real estate and infrastructure. The company invests money on behalf of p...

ABT vs APO — Head-to-Head

Bigger by revenue
ABT
ABT
1.2× larger
ABT
$11.5B
$9.9B
APO
Growing faster (revenue YoY)
APO
APO
+82.3% gap
APO
86.7%
4.4%
ABT
Higher net margin
ABT
ABT
8.6% more per $
ABT
15.5%
6.9%
APO
Faster 2-yr revenue CAGR
APO
APO
Annualised
APO
18.4%
7.2%
ABT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABT
ABT
APO
APO
Revenue
$11.5B
$9.9B
Net Profit
$1.8B
$684.0M
Gross Margin
57.0%
Operating Margin
19.6%
17.8%
Net Margin
15.5%
6.9%
Revenue YoY
4.4%
86.7%
Net Profit YoY
-80.8%
-54.0%
EPS (diluted)
$1.01
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABT
ABT
APO
APO
Q4 25
$11.5B
$9.9B
Q3 25
$11.4B
$9.8B
Q2 25
$11.1B
$6.8B
Q1 25
$10.4B
$5.5B
Q4 24
$11.0B
$5.3B
Q3 24
$10.6B
$7.8B
Q2 24
$10.4B
$6.0B
Q1 24
$10.0B
$7.0B
Net Profit
ABT
ABT
APO
APO
Q4 25
$1.8B
$684.0M
Q3 25
$1.6B
$1.7B
Q2 25
$1.8B
$630.0M
Q1 25
$1.3B
$442.0M
Q4 24
$9.2B
$1.5B
Q3 24
$1.6B
$811.0M
Q2 24
$1.3B
$853.0M
Q1 24
$1.2B
$1.4B
Gross Margin
ABT
ABT
APO
APO
Q4 25
57.0%
Q3 25
55.4%
Q2 25
56.4%
Q1 25
56.9%
Q4 24
55.0%
Q3 24
55.8%
Q2 24
55.6%
Q1 24
55.2%
Operating Margin
ABT
ABT
APO
APO
Q4 25
19.6%
17.8%
Q3 25
18.1%
29.5%
Q2 25
18.4%
12.4%
Q1 25
16.3%
21.3%
Q4 24
17.4%
32.6%
Q3 24
17.5%
26.8%
Q2 24
16.1%
23.9%
Q1 24
13.9%
31.1%
Net Margin
ABT
ABT
APO
APO
Q4 25
15.5%
6.9%
Q3 25
14.5%
17.7%
Q2 25
16.0%
9.2%
Q1 25
12.8%
8.0%
Q4 24
84.1%
28.1%
Q3 24
15.5%
10.4%
Q2 24
12.5%
14.2%
Q1 24
12.3%
20.3%
EPS (diluted)
ABT
ABT
APO
APO
Q4 25
$1.01
$1.09
Q3 25
$0.94
$2.78
Q2 25
$1.01
$0.99
Q1 25
$0.76
$0.68
Q4 24
$5.26
$2.41
Q3 24
$0.94
$1.29
Q2 24
$0.74
$1.35
Q1 24
$0.70
$2.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABT
ABT
APO
APO
Cash + ST InvestmentsLiquidity on hand
$8.9B
Total DebtLower is stronger
$12.9B
$13.4B
Stockholders' EquityBook value
$52.1B
$23.3B
Total Assets
$86.7B
$460.9B
Debt / EquityLower = less leverage
0.25×
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABT
ABT
APO
APO
Q4 25
$8.9B
Q3 25
$7.7B
Q2 25
$7.3B
Q1 25
$6.8B
Q4 24
$8.0B
Q3 24
$7.8B
Q2 24
$7.2B
Q1 24
$6.7B
Total Debt
ABT
ABT
APO
APO
Q4 25
$12.9B
$13.4B
Q3 25
$12.6B
Q2 25
$12.1B
Q1 25
$10.6B
Q4 24
$14.1B
$10.6B
Q3 24
$9.8B
Q2 24
$9.8B
Q1 24
$9.6B
Stockholders' Equity
ABT
ABT
APO
APO
Q4 25
$52.1B
$23.3B
Q3 25
$51.0B
$23.1B
Q2 25
$50.6B
$19.3B
Q1 25
$48.8B
$18.0B
Q4 24
$47.7B
$17.3B
Q3 24
$39.8B
$17.9B
Q2 24
$39.3B
$15.3B
Q1 24
$38.8B
$14.8B
Total Assets
ABT
ABT
APO
APO
Q4 25
$86.7B
$460.9B
Q3 25
$84.2B
$449.5B
Q2 25
$84.0B
$419.6B
Q1 25
$81.4B
$395.0B
Q4 24
$81.4B
$377.9B
Q3 24
$74.4B
$368.7B
Q2 24
$73.0B
$346.5B
Q1 24
$72.5B
$334.1B
Debt / Equity
ABT
ABT
APO
APO
Q4 25
0.25×
0.57×
Q3 25
0.55×
Q2 25
0.63×
Q1 25
0.59×
Q4 24
0.30×
0.61×
Q3 24
0.55×
Q2 24
0.64×
Q1 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABT
ABT
APO
APO
Operating Cash FlowLast quarter
$3.3B
$4.7B
Free Cash FlowOCF − Capex
$2.6B
FCF MarginFCF / Revenue
22.9%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
1.87×
6.83×
TTM Free Cash FlowTrailing 4 quarters
$7.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABT
ABT
APO
APO
Q4 25
$3.3B
$4.7B
Q3 25
$2.8B
$303.0M
Q2 25
$2.0B
$1.3B
Q1 25
$1.4B
$1.0B
Q4 24
$2.9B
$-4.0M
Q3 24
$2.7B
$1.9B
Q2 24
$2.0B
$1.3B
Q1 24
$1.0B
$70.0M
Free Cash Flow
ABT
ABT
APO
APO
Q4 25
$2.6B
Q3 25
$2.3B
Q2 25
$1.5B
Q1 25
$933.0M
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$1.4B
Q1 24
$627.0M
FCF Margin
ABT
ABT
APO
APO
Q4 25
22.9%
Q3 25
20.2%
Q2 25
13.9%
Q1 25
9.0%
Q4 24
19.6%
Q3 24
20.2%
Q2 24
13.8%
Q1 24
6.3%
Capex Intensity
ABT
ABT
APO
APO
Q4 25
6.0%
Q3 25
4.4%
Q2 25
4.5%
Q1 25
4.7%
Q4 24
6.6%
Q3 24
5.2%
Q2 24
5.1%
Q1 24
4.0%
Cash Conversion
ABT
ABT
APO
APO
Q4 25
1.87×
6.83×
Q3 25
1.70×
0.17×
Q2 25
1.15×
2.00×
Q1 25
1.07×
2.29×
Q4 24
0.31×
-0.00×
Q3 24
1.64×
2.29×
Q2 24
1.51×
1.56×
Q1 24
0.84×
0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABT
ABT

Segment breakdown not available.

APO
APO

Retirement Services Segment$8.5B86%
Asset Management1$681.0M7%
Principal Investing Segment$624.0M6%
Management Service Incentive$96.0M1%

Related Comparisons